Buy or sell Color stock pre IPO via an EquityZen fund
American Genomic Testing Company
About Color Stock
Color is a population health technology company that aims to enable the delivery of advanced healthcare through clinical genetics. Color’s Population Genomics Platform offers modular and end-to-end solutions that enable organizations to effectively build and scale population health programs. Color’s partners include NorthShore University Health System, the National Institutes of Health (NIH), Ochsner Health System, Verily, Visa, Levi Strauss and Salesforce.
Color launched its first product in 2015 and is based in Burlingame, California. Notable investors in Color include T. Rowe Price, Viking Global Investors, and General Catalyst.
General Catalyst Partners
T. Rowe Price
Chief Executive Officer
fiercebiotech - May, 20 2020
axial - Apr, 28 2020
Genome Web - Jan, 10 2020
TechCrunch - Oct, 10 2019